Po W. Wang

2.8k total citations
88 papers, 2.0k citations indexed

About

Po W. Wang is a scholar working on Psychiatry and Mental health, Clinical Psychology and Epidemiology. According to data from OpenAlex, Po W. Wang has authored 88 papers receiving a total of 2.0k indexed citations (citations by other indexed papers that have themselves been cited), including 62 papers in Psychiatry and Mental health, 15 papers in Clinical Psychology and 10 papers in Epidemiology. Recurrent topics in Po W. Wang's work include Bipolar Disorder and Treatment (60 papers), Electroconvulsive Therapy Studies (32 papers) and Schizophrenia research and treatment (16 papers). Po W. Wang is often cited by papers focused on Bipolar Disorder and Treatment (60 papers), Electroconvulsive Therapy Studies (32 papers) and Schizophrenia research and treatment (16 papers). Po W. Wang collaborates with scholars based in United States, China and South Korea. Po W. Wang's co-authors include Terence A. Ketter, Cecylia Nowakowska, Connie M. Strong, Claudia Santosa, Shefali Miller, Shelley J. Hill, John O. Brooks, Olga Becker, Farnaz Hooshmand and Rebecca A. Chandler and has published in prestigious journals such as Neurology, Journal of Hazardous Materials and Biological Psychiatry.

In The Last Decade

Po W. Wang

83 papers receiving 1.9k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Po W. Wang United States 29 1.2k 431 391 285 251 88 2.0k
Takuya Saito Japan 26 983 0.8× 654 1.5× 229 0.6× 669 2.3× 315 1.3× 105 3.6k
Cenk Tek United States 30 1.7k 1.4× 788 1.8× 423 1.1× 456 1.6× 101 0.4× 72 3.0k
Isabelle E. Bauer United States 27 1.0k 0.8× 404 0.9× 267 0.7× 268 0.9× 104 0.4× 63 2.1k
Jakub Z. Konarski Canada 28 1.5k 1.2× 510 1.2× 297 0.8× 478 1.7× 112 0.4× 47 2.8k
Ru‐Band Lu Taiwan 31 875 0.7× 360 0.8× 131 0.3× 291 1.0× 377 1.5× 110 2.7k
Kunitoshi Kamijima Japan 30 775 0.6× 542 1.3× 439 1.1× 566 2.0× 113 0.5× 108 3.0k
Peggy J. Pazzaglia United States 20 1.4k 1.2× 625 1.5× 298 0.8× 421 1.5× 83 0.3× 37 2.3k
Sameer Jauhar United Kingdom 27 1.8k 1.5× 533 1.2× 325 0.8× 673 2.4× 143 0.6× 103 3.4k
Andreas Erfurth Germany 27 1.3k 1.0× 488 1.1× 207 0.5× 428 1.5× 107 0.4× 139 2.6k
Vincenzo S. Basile Canada 27 1.1k 0.9× 322 0.7× 96 0.2× 275 1.0× 113 0.5× 51 2.4k

Countries citing papers authored by Po W. Wang

Since Specialization
Citations

This map shows the geographic impact of Po W. Wang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Po W. Wang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Po W. Wang more than expected).

Fields of papers citing papers by Po W. Wang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Po W. Wang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Po W. Wang. The network helps show where Po W. Wang may publish in the future.

Co-authorship network of co-authors of Po W. Wang

This figure shows the co-authorship network connecting the top 25 collaborators of Po W. Wang. A scholar is included among the top collaborators of Po W. Wang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Po W. Wang. Po W. Wang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Hooshmand, Farnaz, Anda Gershon, Bernardo Dell’Osso, et al.. (2018). Antidepressants have complex associations with longitudinal depressive burden in bipolar disorder. Journal of Affective Disorders. 246. 836–842. 5 indexed citations
3.
Miller, Shefali, et al.. (2018). Longer-Term Effectiveness and Tolerability of Adjunctive Open Lurasidone in Patients With Bipolar Disorder. Journal of Clinical Psychopharmacology. 38(3). 207–211. 5 indexed citations
4.
Rasgon, Natalie, Hyun Kim, Kathryn C. Goffin, et al.. (2017). Lifetime eating disorder comorbidity associated with delayed depressive recovery in bipolar disorder. International Journal of Bipolar Disorders. 5(1). 25–25. 15 indexed citations
5.
Hooshmand, Farnaz, et al.. (2017). Episode accumulation associated with hastened recurrence and delayed recovery in bipolar disorder. Journal of Affective Disorders. 227. 657–664. 10 indexed citations
6.
Miller, Shefali, et al.. (2016). Current irritability associated with hastened depressive recurrence and delayed depressive recovery in bipolar disorder. International Journal of Bipolar Disorders. 4(1). 15–15. 9 indexed citations
7.
Miller, Shefali, Po W. Wang, Farnaz Hooshmand, et al.. (2016). Current irritability robustly related to current and prior anxiety in bipolar disorder. Journal of Psychiatric Research. 79. 101–107. 12 indexed citations
8.
Ketter, Terence A., Shefali Miller, Bernardo Dell’Osso, & Po W. Wang. (2015). Treatment of bipolar disorder: Review of evidence regarding quetiapine and lithium. Journal of Affective Disorders. 191. 256–273. 33 indexed citations
9.
Xu, Min, Xiaofei Lv, Lan Xie, et al.. (2015). Discrete associations of the GCKR variant with metabolic risk in a Chinese population: longitudinal change analysis. Diabetologia. 59(2). 307–315. 9 indexed citations
10.
Miller, Shefali, Joachim Hallmayer, Po W. Wang, et al.. (2012). Brain-derived neurotrophic factor val66met genotype and early life stress effects upon bipolar course. Journal of Psychiatric Research. 47(2). 252–258. 29 indexed citations
11.
Kenna, Heather A., et al.. (2011). Gender-specific lipid profiles in patients with bipolar disorder. Journal of Psychiatric Research. 45(8). 1036–1041. 12 indexed citations
12.
Wang, Po W., Shelley J. Hill, Meredith E. Childers, et al.. (2011). Open adjunctive ziprasidone associated with weight loss in obese and overweight bipolar disorder patients. Journal of Psychiatric Research. 45(8). 1128–1132. 8 indexed citations
13.
Rasgon, Natalie, et al.. (2010). Metabolic dysfunction in women with bipolar disorder: the potential influence of family history of type 2 diabetes mellitus. Bipolar Disorders. 12(5). 504–513. 19 indexed citations
14.
Brooks, John O., Allyson Rosen, Po W. Wang, et al.. (2009). Dorsolateral and dorsomedial prefrontal gray matter density changes associated with bipolar depression. Psychiatry Research Neuroimaging. 172(3). 200–204. 40 indexed citations
15.
Brooks, John O., Po W. Wang, Allyson Rosen, et al.. (2008). Decreased prefrontal, anterior cingulate, insula, and ventral striatal metabolism in medication-free depressed outpatients with bipolar disorder. Journal of Psychiatric Research. 43(3). 181–188. 78 indexed citations
16.
Wang, Po W., Roy H. Perlis, Carlos A. Zarate, et al.. (2006). Overweight and obesity in bipolar disorders. Journal of Psychiatric Research. 40(8). 762–764. 50 indexed citations
17.
Wang, Po W. & Terence A. Ketter. (2005). Clinical use of carbamazepine for bipolar disorders. Expert Opinion on Pharmacotherapy. 6(16). 2887–2902. 6 indexed citations
18.
Ketter, Terence A., et al.. (2005). Dermatology Precautions and Slower Titration Yield Low Incidence of Lamotrigine Treatment-Emergent Rash. The Journal of Clinical Psychiatry. 66(5). 642–645. 38 indexed citations
19.
Nowakowska, Cecylia, Connie M. Strong, Claudia Santosa, Po W. Wang, & Terence A. Ketter. (2004). Temperamental commonalities and differences in euthymic mood disorder patients, creative controls, and healthy controls. Journal of Affective Disorders. 85(1-2). 207–215. 144 indexed citations
20.
Ketter, Terence A., et al.. (2003). Psychotic bipolar disorders: dimensionally similar to or categorically different from schizophrenia?. Journal of Psychiatric Research. 38(1). 47–61. 64 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026